(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

PERKS 4 U

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

PERKS 4 U

ST13

US500000086756074

Class

35

Filing

86756074

Registration

5157052

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

38

Latest update

03/08/2026

Trademark type

Word

Nice classes

35

Filing date

09/14/2015

Registration date

03/07/2017

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/07/2023

Last transaction

03/08/2026

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

12/12/2015

First use in commerce

12/12/2015

Drawing code

4

Owner type

99

Owner location

Rochester, NY, US

Examiner

BURNS, ELLEN

Law office

M70

Current location

TMO LAW OFFICE 116

Holders and representatives

Holders

Excellus Health Plan, Inc.

Representatives

George R. McGuire Bond Schoeneck & King Pllc

Technical classification

Nice Classes

Class 35

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Administration of a program for enabling participants to obtain discounts on products and services

Publications

History of USPTO decisions and trademark events.

38 publications found

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

03/07/2026

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

09/07/2023

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

09/07/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

09/06/2023

E815

TEAS SECTION 8 & 15 RECEIVED

03/07/2023

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

03/07/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

03/07/2017

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

02/01/2017

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

01/31/2017

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

01/25/2017

SUPC

STATEMENT OF USE PROCESSING COMPLETE

01/24/2017

EX1G

SOU EXTENSION 1 GRANTED

01/24/2017

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

01/21/2017

IUAF

USE AMENDMENT FILED

01/04/2017

EISU

TEAS STATEMENT OF USE RECEIVED

01/04/2017

NREV

NOTICE OF REVIVAL - E-MAILED

01/04/2017

TPEX

SOU EXTENSION RECEIVED WITH TEAS PETITION

01/04/2017

PETG

PETITION TO REVIVE-GRANTED

01/04/2017

PROA

TEAS PETITION TO REVIVE RECEIVED

01/04/2017

MAB6

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED

12/12/2016

ABN6

ABANDONMENT - NO USE STATEMENT FILED

12/12/2016

EXT1

SOU EXTENSION 1 FILED

11/10/2016

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

05/10/2016

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/15/2016

PUBO

PUBLISHED FOR OPPOSITION

03/15/2016

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/24/2016

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/04/2016

XAEC

EXAMINER'S AMENDMENT ENTERED

02/04/2016

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

02/04/2016

GNEA

EXAMINERS AMENDMENT E-MAILED

02/04/2016

CNEA

EXAMINERS AMENDMENT -WRITTEN

02/04/2016

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

12/31/2015

GNRT

NON-FINAL ACTION E-MAILED

12/31/2015

CNRT

NON-FINAL ACTION WRITTEN

12/31/2015

DOCK

ASSIGNED TO EXAMINER

12/29/2015

MPMK

NOTICE OF PSEUDO MARK E-MAILED

09/18/2015

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/17/2015

NWAP

NEW APPLICATION ENTERED

09/17/2015

Continuous trademark protection

Get notified about every new filing that threatens PERKS 4 U or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.